Customize your JAMA Network experience by selecting one or more topics from the list below.
In the Editorial entitled “Statins for Primary Prevention: The Debate Is Intense, But the Data Are Weak”1 published in the January 2017 issue of JAMA Internal Medicine, incorrect data were reported in the text. In the first sentence of the second paragraph on the first page, the absolute benefit for use of statins should have been reported as 0.20%, rather than 0.43%, for cardiovascular mortality. This article was corrected online.
Incorrect Data in Text. JAMA Intern Med. 2020;180(4):618. doi:10.1001/jamainternmed.2020.0124
Coronavirus Resource Center
Create a personal account or sign in to: